ArticleJPRAS open2026
Early dye laser treatment of hypertrophic sternotomy scars with prominent vascular component.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: A considerable percentage of patients develop hypertrophic scarring due to the healing process after heart surgery. The purpose of this study was to determine whether PDL applied on the day of suture removal, is even more successful in minimizing symptoms that impair the patient's quality of life and the cosmetic appearance of scars from median sternotomy cardiac surgery procedure. Materials/methods: A total of 12 patients with hypertrophic sternotomy scars resulting from cardiac surgeries underwent 4-5 treatment sessions with Dye laser as soon as the wound's sutures were taken out. After 40 days, the patient was re-assessed using an in-vivo multispectral skin imaging optical evaluation of the skin structures. Images were captured before and after each treatment, as well as 6 and 12 months after the last treatment. Twelve months after the last session each patient's level of improvement was assessed using the Vancouver Scar Scale (VSS). Twelve months following the conclusion of treatments, the patients were given photographs and filled out a satisfaction questionnaire. Results: Analysis of the VSS subscales after 1 year from the last laser treatment showed significant improvement in all parameters examined. Nine patients (75%) were very satisfied, 3 patients (25%) were satisfied, and no patients expressed dissatisfaction or insufficient satisfaction. Relevant side effects were absent. Before and after all treatments, multispectral and hemoglobin analyses showed overall patient's improvement. Conclusions: PDL therapy has been proven to physically improve hypertrophic sternotomy scars with few side effects, reducing or even completely avoiding the need for reconstructive surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.